Riproximin is a recently discovered type II ribosome inactivating protein with potential for treating cancer

Autor: Adwan, Hassan, Bayer, Helene, Pervaiz, Asim, Sagini, Micah, Berger, Martin R.
Zdroj: In Biotechnology Advances 1 November 2014 32(6):1077-1090
Databáze: ScienceDirect